I wonder how he is doing now.
Many studies over decades show that nocturnal supplemental oxygen by itself:
(1) Reduces loop gain (i.e., the gain, or chemoreflex responsiveness, of the negative feedback loop that regulates ventilation) in people with high loop-gain sleep apnea (an unstable ventilatory control system).
(2) Reduces peripheral and central chemoresponsiveness in high loop-gain sleep apnea.
(3) Stabilizes the ventilatory control system in high loop-gain sleep apnea.
(4) Reduces Cheyne–Stokes respiration and periodic breathing pattern in high loop-gain sleep apnea.
(5) Reduces the AHI, especially the central component of the AHI, in high loop-gain sleep apnea.
(6) Stabilizes nocturnal oxygen saturation levels.
Relying on the decades of research on oxygen therapy for high loop-gain sleep apnea, the following December 2020 study:
“Demonstrates for the first time in elderly adults without heart disease that intervention with supplemental oxygen in the clinical range will ameliorate central apneas and hypopneas by decreasing the propensity to central apnea through decreased chemoreflex sensitivity, even in the absence of a reduction in the plant gain. Thus, the study provides physiological evidence for use of supplemental oxygen as therapy for mild-to-moderate SDB [sleep-disordered breathing] in this vulnerable population.”
Amelioration of sleep-disordered breathing with supplemental oxygen in older adults
Ruchi Rastogi, M.S. Badr, A. Ahmed, and S. Chowdhuri
December 1, 2020
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792842/